Research Points to Translational Path Toward Precision Immunotherapies for EGFR-Mutant NSCLC

Smoking Cessation in Lung Cancer Screening: The Latest Randomized Controlled Trial Evidence

… the US Veterans Health Administration (VA). 5 , 7  This research sought to determine the key components … the trials were conducted in 76 clinics with over 5,700 research participants nationwide.   SCALE Collaboration … support was delivered to clinical providers; of note, the research team did not intervene directly with patients. 20 …

First Presidential Symposium to Explore Practice-Changing Research in Lung Cancer Screening, Immune Oncology

… First Presidential Symposium to Explore Practice-Changing Research in Lung Cancer Screening, Immune Oncology …

Ongoing Research Looks at Optimizing Lung Cancer Screening Programs

… false positives against delayed diagnosis. … Ongoing Research Looks at Optimizing Lung Cancer Screening Programs … …

Wu-Kong28 Data Support Sunvozertinib as First-Line Treatment Option for EGFR-Mutant NSCLC, Researcher Says

… as First-Line Treatment Option for EGFR-Mutant NSCLC, Researcher Says … Haleigh Behrman …

Research Supports Use of Lung Nodule Programs to Improve Early Detection Efforts

… for lung cancer screening based on existing guidelines. … Research Supports Use of Lung Nodule Programs to Improve Early …

Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC

… weight gain represents a promising avenue for further research. The successful combination of a GLP-1-RA and a TKI … treatment strategy. A new prospective cohort study by our research group specifically addresses this issue in patients …

Keynote Address Explores the Future of Biomarkers in the ADC Era

… R. Hirsch outlined the current state of knowledge in ADC research, as well as what still needs to be learned. … Keynote …